The World Health Organization has added new curative treatments for hepatitis C to its essential medicines list, but the UN agency said prices needed to fall to make them accessible to patients in poorer countries.
The treatment o
About 240 million people worldwide have chronic hepatitis B virus with the highest rates of infection in Africa and Asia, according to World Health Organisation (WHO).
People with chronic hepatitis B infection, which spreads throu
Adoption of safety-engineered syringes is absolutely critical to protecting people worldwide from becoming infected with HIV, hepatitis and other diseases, said a top official of the World Health Organisation (WHO).
A two-drug combination being tested by Merck & Co to treat hepatitis C cured 98 percent of previously untreated patients without cirrhosis in a midstage clinical trial, providing the latest evidence that the US drugmaker will be highly compe
US health regulators have strengthened the warnings on two blood cancer drugs to reflect the risk that they may reactivate the hepatitis B virus in patients previously infected with the disease.
The warnings affect GlaxoSmithKline
The World Health Organization (WHO) is urging governments to act against the five hepatitis viruses that can cause severe liver infections and lead to 1.4 million deaths every year, as part of World Hepatitis Day which falls on July 28.
The Emirates Gastroenterology and Hepatology Society (EGHS)-Emirates Medical Association has announced the launch of a two-month Hepatitis C virus awareness campaign in the emirates.
Leading pharma group Roche is the official spon
Hepatitis C is highly prevalent in the Mena region with approximately 9.2 million individuals infected with this condition, according to a report.
The announcement was made at a press conference in Dubai on World Hepatitis Day, attended by
Egypt has the highest rates of new hepatitis C virus (HCV) infection in the world, according to a new study.
The study, published in the Proceedings of the National Academy of Sciences, also estimates more than 500,000 new HCV infections o
Two international studies of a new drug, telbivudine, have produced potentially good news for hepatitis B patients.
The studies show that it suppresses the virus that damages the liver faster and better than other treatments.